Announcements Trials

Browse Landscape

Phase

Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumor 104 Advanced Solid Tumors 92 Solid Tumor 69 Mesothelioma 42 Mesothelioma, Malignant 41 Solid Tumors 37 Carcinoma, Non-Small-Cell Lung 25 Solid Tumor, Adult 22 Stomach Neoplasms 15 Ovarian Neoplasms 15 Esophageal Neoplasms 15 Melanoma 13 Colorectal Neoplasms 13 Carcinoma, Renal Cell 13 Endometrial Neoplasms 11 Unspecified Adult Solid Tumor, Protocol Specific 10 Pancreatic Neoplasms 10 Neoplasms 10 Neoplasm Metastasis 10 Advanced Malignant Solid Tumor 10 Uterine Cervical Neoplasms 9 Malignant Solid Tumor 9 Lung Neoplasms 9 Breast Neoplasms 9 Triple Negative Breast Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Sarcoma 8 Advanced or Metastatic Solid Tumors 8 Carcinoma, Hepatocellular 7 Small Cell Lung Carcinoma 6

Interventions

Pharmaceutical Preparations 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × All Solid Tumors × Other solid neoplasm × Clear all

NCT01711398 2015-02-12

IP N02

Elro Pharma

Phase 1/2 Completed

Other solid neoplasm

All Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡